In vitro selection and analysis of human immunodeficiency virus Type 1 resistant to derivatives of β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

被引：13

作者：

Hammond, JL

Parikh, UM

Koontz, DL

Schlueter-Wirtz, S

Chu, CK

Bazmi, HZ

Schinazi, RF

Mellors, JW

机构：

[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Dept Med, Pittsburgh, PA 15261 USA

[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA

[3] Vet Affairs Med Ctr, Georgia VA Res Ctr AIDS & HIV Infect, Atlanta, GA 30033 USA

[4] Univ Georgia, Coll Pharm, Athens, GA 30602 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 09期

关键词：

D O I：

10.1128/AAC.49.9.3930-3932.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Serial passage of human immunodeficiency virus type 1 in MT-2 cells in increasing concentrations of the D-and L-enantiomers of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine (d4FC) resulted in the selection of viral variants with reverse transcriptase substitutions M184I or M184V for L-d4FC and I63L, K65R, K70N, K70E, or R172K for D-d4FC. Phenotypic analysis of site-directed mutants defined the role of these mutations in reducing susceptibility to L- or D-d4FC.

引用

页码：3930 / 3932

页数：3

共 50 条

[31] Synthesis and spectroscopic analysis of 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T) 5′-thiophosphoramidates
Miao, ZW
Feng, YP
Fu, H
Tu, GZ
Zhao, YF
ACTA CHIMICA SINICA, 2002, 60 (10) : 1887 - 1892
[32] Metabolism of 2′,3′-dideoxy-2′,3′-didehydro-β-L(-)-5-flurocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus β-D(+) nucleoside analogs in vitro
Dutschman, GE
Bridges, EG
Liu, SH
Gullen, E
Guo, X
Kukhanova, M
Cheng, YC
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1799 - 1804
[33] NOVEL MUTATION (V75T) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS RESISTANCE TO 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE IN CELL-CULTURE
LACEY, SF
LARDER, BA
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) : 1428 - 1432
[34] Anti-human immunodeficiency virus type 1 activity and resistance profile of 2,3′-didehydro-3′-deoxy-4′-ethynylthymidine in vitro
Nitanda, T
Wang, X
Kumamoto, H
Haraguchi, K
Tanaka, H
Cheng, YC
Baba, M
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3355 - 3360
[35] INVITRO SELECTION OF VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE
GAO, Q
GU, ZX
PARNIAK, MA
LI, XG
WAINBERG, MA
JOURNAL OF VIROLOGY, 1992, 66 (01) : 12 - 19
[36] Synthesis and antiviral activity of aryl phosphoramidate derivatives of β-D- and β-L-C-5-Substituted 2′,3′-didehydro-2′,3′-dideoxy-uridine bearing linker arms
Ladurée, D
Fossey, C
Delbederi, Z
Sugeac, E
Schmidt, S
Laumond, G
Aubertin, AM
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2005, 20 (06) : 533 - 549
[37] NUCLEOSIDES AND NUCLEOTIDES .87. SYNTHESIS OF 2',3'-DIDEOXY-3'-METHYLIDENETHYMIDINE AND 2',3'-DIDEHYDRO-2',3'-DIDEOXY-3'-METHYLTHYMIDINE - DEOXYGENATION OF THE ALLYLIC ALCOHOL SYSTEM IN 3'-DEOXY-3'-METHYLIDENE-5-METHYLURIDINE
MATSUDA, A
OKAJIMA, H
UEDA, T
HETEROCYCLES, 1989, 29 (01) : 25 - 28
[38] NOVEL SYNTHESIS OF (+/-)-CIS-4-AMINO-2-CYCLOPENTENE-1-METHANOL, A KEY INTERMEDIATE IN THE PREPARATION OF CARBOCYCLIC 2',3'-DIDEHYDRO-2',3'-DIDEOXY NUCLEOSIDES
NORMAN, MH
ALMOND, MR
REITTER, BE
RAHIM, SG
SYNTHETIC COMMUNICATIONS, 1992, 22 (22) : 3197 - 3204
[39] In vitro selection and characterization of human immunodeficiency virus type 1 resistant to zidovudine and tenofovir
Park, S.-S.
Hong, S.-K.
Lee, S.-G.
Yoon, J.-S.
Yoo, W.-C.
Paik, S.-Y.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2007, 26 (05): : 453 - 457
[40] GENERATION OF DRUG-RESISTANT VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY INVITRO PASSAGE IN INCREASING CONCENTRATIONS OF 2',3'-DIDEOXYCYTIDINE AND 2',3'-DIDEOXY-3'-THIACYTIDINE
GAO, Q
GU, ZX
HISCOTT, J
DIONNE, G
WAINBERG, MA
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) : 130 - 133

← 1 2 3 4 5 →